Although inhaled and intranasal corticosteroids are first-line therapy for asthma and allergic
rhinitis, there has recently been an increasing awareness of their propensity to produce …

Bronchial asthma and allergic rhinitis are among the most common diseases of modern
society and to an increasing degree a major cause of illness, hospitalization, loss of …

Topical corticosteroids remain the most efficacious single treatment for asthma and rhinitis,
despite the emergence of newer drugs in recent years. The antiinflammatory properties of …

The pharmacokinetic and pharmacodynamic effects of inhaled corticosteroids (ICS) have
shaped the efficacy and safety of these agents in the treatment of asthma. Important …

Introduction The commercially available inhaled corticosteroids (ICS) for asthma treatment
are beclomethasone dipropionate (BDP), budesonide (BUD), flunisolide (FLU), fluticasone …

■ Abstract The safety and efficacy of intranasal corticosteroids (INCs) are well established
for the management of allergic rhinitis, rhinosinusitis, and nasal polyps. As seen in …

Objectives: To assess similarities and differences among currently available inhaled
corticosteroids (ICS) for treatment of asthma, with special emphasis on factors that may affect …

There has been increasing concern in the medical literature about the safety of inhaled and
nasal corticosteroids, since many patients, both adults and children, are increasingly …

Objective: To review the basis for the estimated comparative daily dosages of inhaled
corticosteroids for children and adults that are presented in the National Heart, Lung, and …

BACKGROUND: Inhaled corticosteroids (ICSs) are the most effective therapy for the
management of persistent asthma. The aim of ICS therapy is to achieve a high anti …